Search - tctmd.com

Displaying 181 - 200 of 205

Sort: Relevancy | Date

News Daily News

Novel Device Shows Promise for Safe, Effective LAA Closure

Yael L. Maxwell

October 12, 2012

News Daily News

Watchman Device for LAA Closure Provides Net Clinical Benefit vs. Warfarin in A-fib Patients

September 27, 2012

News Daily News

El Dispositivo Watchman para el Cierre del AAI Ofrece Beneficios Clínicos Netos comparado con la Warfarina en Pacientes con FA

September 27, 2012

News Industry News

Boston Scientific WATCHMAN® Left Atrial Appendage Closure Device Receives CE Mark Approval For Expanded Use

August 26, 2012

News Industry News

Boston Scientific Completes Patient Enrollment in PREVAIL Study for First-in-Class WATCHMAN Device

July 02, 2012

Presentation TVT 2012

The Watchman Clinical Studies Program (Warfarin Eligible): Perspectives, New Insights, and Future Directions

Presenter: Saibal Kar

June 05, 2012

Presentation TVT 2012

Taped Case Study: The Watchman Procedure(2)

Presenter: Saibal Kar

June 05, 2012

Presentation TVT 2012

ASAP Results: The Watchman in Warfarin Ineligible Patients

Presenter: Shephal Doshi

June 05, 2012

News Daily News

Watchman Works Just as Well Without Warfarin-Protected Transition

June 01, 2012

News Daily News

El Watchman Funciona Igual de Bien sin Transición Protegida con Warfarina

June 01, 2012

Presentation

Watchman LAA Closure in A-fib Patients with Contraindication to Oral Anticoagulation

Presenter: Vivek Y. Reddy

May 30, 2012

News Industry News

Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy

May 11, 2012

News Industry News

Boston Scientific Announces New Clinical Data to be Presented at ACC 2012 on the Market-Leading PROMUS Element™ Stent

March 20, 2012

News Daily News

Lack of Complete Seal with Watchman Device Common, But No Cause for Alarm

Jason Kahn

March 05, 2012

News Daily News

La Falta de Sellado Completo con el Dispositivo Watchman es Común pero No hay Razón para la Alarma

Jason Kahn

March 05, 2012

Presentation

The Clinical Impact of Incomplete LAA Closure With the Watchman Device in Patients With A-fib

Presenter: J. Viles-Gonzalez

February 26, 2012

Presentation

Impacto Clínico del Cierre Incompleto del AAI con el Dispositivo Watchman en Pacientes con Fibrilación Auricular

Presenter: J. Viles-Gonzalez

February 26, 2012

Presentation ISET 2012

LAA Closure: The Watchman Devices, Lessons Learned from the Clinical Trials

Presenter: Ramon Quesada

January 16, 2012

News Industry News

Boston Scientific's WATCHMAN® Device Implanted in First Patients in Latin America

November 15, 2011

News Industry News

Boston Scientific Announces Schedule of Events at TCT Scientific Symposium

November 01, 2011

Advertisement

Novel Device Shows Promise for Safe, Effective LAA Closure

Watchman Device for LAA Closure Provides Net Clinical Benefit vs. Warfarin in A-fib Patients

El Dispositivo Watchman para el Cierre del AAI Ofrece Beneficios Clínicos Netos comparado con la Warfarina en Pacientes con FA

Boston Scientific WATCHMAN® Left Atrial Appendage Closure Device Receives CE Mark Approval For Expanded Use

Boston Scientific Completes Patient Enrollment in PREVAIL Study for First-in-Class WATCHMAN Device

The Watchman Clinical Studies Program (Warfarin Eligible): Perspectives, New Insights, and Future Directions

Taped Case Study: The Watchman Procedure(2)

ASAP Results: The Watchman in Warfarin Ineligible Patients

Watchman Works Just as Well Without Warfarin-Protected Transition

El Watchman Funciona Igual de Bien sin Transición Protegida con Warfarina

Watchman LAA Closure in A-fib Patients with Contraindication to Oral Anticoagulation

Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy

Boston Scientific Announces New Clinical Data to be Presented at ACC 2012 on the Market-Leading PROMUS Element™ Stent

Lack of Complete Seal with Watchman Device Common, But No Cause for Alarm

La Falta de Sellado Completo con el Dispositivo Watchman es Común pero No hay Razón para la Alarma

The Clinical Impact of Incomplete LAA Closure With the Watchman Device in Patients With A-fib

Impacto Clínico del Cierre Incompleto del AAI con el Dispositivo Watchman en Pacientes con Fibrilación Auricular

LAA Closure: The Watchman Devices, Lessons Learned from the Clinical Trials

Boston Scientific's WATCHMAN® Device Implanted in First Patients in Latin America

Boston Scientific Announces Schedule of Events at TCT Scientific Symposium

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content